Notably, the expression of GPER1 was significantly down-regulated in PCs from clinically overt diseases, as MM and PCL, with respect to normal PCs or PCs from premalignant conditions (MGUS, SMM), and lower GPER1 expression correlated with inferior overall survival of MM patients. The gene discussed is GPER1; the disease is Miyoshi myopathy.